The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection.
The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection.
复制标题
单克隆抗毒素抗体（Actoxumab-Bezlotoxumab）治疗促进艰难梭菌感染小鼠肠道微生物群的正常化。
DOI：
10.3389/fcimb.2016.00119
复制
发表时间：
2016
影响因子：
5.7
通讯作者：
Chen,Xinhua
中科院分区：
文献类型：
--
作者：
Džunková,Mária;D'Auria,Giuseppe;Xu,Hua;Huang,Jun;Duan,Yinghua;Moya,Andrés;Kelly,CiaránP;Chen,Xinhua
